Medical Device Network on MSN
Roche and KlinRisk’s AI-powered kidney tool gains CE mark
Roche and KlinRisk have secured CE mark approval for their AI-driven risk stratification tool, designed for evaluating the progression of kidney function decline. The new tool, a part of Roche's newly ...
The tool assesses progressive decline in kidney function and will be launched as part of Roche's new chronic kidney disease algorithm panel.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback